Trial Profile
A Study to Evaluate the Clinical and Economic Outcomes of Early Versus Late Initiation of Branded Celecoxib in Patients With Osteoarthritis (OA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research